The G allele of transcobalamin 2 c.776C→G is associated with an unfavorable lipoprotein profile

Annals of Nutrition and Metabolism

Volumn 57, Issue 2, 2010, Pages 112-115

  Semmler, Alexander ^a,b   Farmand, Susan ^b   Moskau, Susanna ^b   Stoffel Wagner, Birgit ^b   Linnebank, Michael ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Homocysteine; Lipoprotein profile; Transcobalamin 2 c.776C G

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE SYNTHASE; REDUCED FOLATE CARRIER; REDUCED FOLATE CARRIER 1; TRANSCOBALAMIN II; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMINO ACID METABOLISM; ARTICLE; CAUCASIAN; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGENY; SPOUSE;

ADULT; AGED; ALLELES; CEREBROVASCULAR DISORDERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; LIPOPROTEINS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; REDUCED FOLATE CARRIER PROTEIN; TRANSCOBALAMINS;

EID: 77957783959     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320418     Document Type: Article

References (23)

1. Obeid R, Herrmann W: Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009;583:1215-1225.
2. Mudd SH, Levy HL, Kraus JP: Disorders of transsulfuration; in Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler K, Vogelstein B (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001, pp 2007-2056.
3. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, Kimura H: Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 2004;279:52961-52969.
4. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G: Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995;274:1526-1533.
5. Olszewski AJ, McCully KS: Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis 1991;88:61-68.
6. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107:1263-1273.
7. Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, Pownall HJ, Yang X, Wang H: Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006;99:598-606.
8. O K, Lynn EG, Chung YH, Siow YL, Man RY, Choy PC: Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta 1998;1393:317-324.
9. Kitami T, Rubio R, O'Brien W, Quackenbush J, Nadeau JH: Gene-environment interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice. Physiol Genomics 2008;35:182-190.
10. Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S: Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006;5:1.
11. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T: Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke 2005;36:5-8.
12. Linnebank M, Moskau S, Farmand S, Fliessbach K, Kolsch H, Bos M, Grothe C, Becker D, Harbrecht U, Pohl C, Wullner U, Klockgether T: Homocysteine and carotid intimamedia thickness in a German population: lack of clinical relevance. Stroke 2006;37:2840-2842.
13. Afman LA, Van Der Put NM, Thomas CM, Trijbels JM, Blom HJ: Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 2001;94:159-166.
14. Castel-Dunwoody KM, Kauwell GP, Shelnutt KP, Vaughn JD, Griffin ER, Maneval DR, Theriaque DW, Bailey LB: Transcobalamin 776cC→G polymorphism negatively affects vitamin B-12 metabolism. Am J Clin Nutr 2005;81:1436-1441.
15. Alessio AC, Hoehr NF, Siqueira LH, Bydlowski SP, Annichino-Bizzacchi JM: Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations: association with MTH-FR C677T and A1298C and MTRR A66G polymorphisms in healthy children. Thromb Res 2007;119:571-577.
16. Lievers KJ, Afman LA, Kluijtmans LA, Boers GH, Verhoef P, den Heijer M, Trijbels FJ, Blom HJ: Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem 2002;48:1383-1389.
17. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J: Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007;28:856-865.
18. Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R: Transcobalamin II 775G→C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 2002;100:718-720.
19. Olszewski AJ, Szostak WB, Bialkowska M, Rudnicki S, McCully KS: Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 1989;75:1-6.
20. Sharma M, Rai SK, Tiwari M, Chandra R: Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol 2007;574:49-60.
21. Hirche F, Schroder A, Knoth B, Stangl GI, Eder K: Methionine-induced elevation of plasma homocysteine concentration is associated with an increase of plasma cholesterol in adult rats. Ann Nutr Metab 2006;50:139-146.
22. Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin D, O K: Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 2005;288: E1002-E1010.
23. Malanovic N, Streith I, Wolinski H, Rechberger G, Kohlwein SD, Tehlivets O: S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis. J Biol Chem 2008;283:23989-23999.